Ding Ma
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 56
- Cancer Cells and Metastasis 12
- Cancer-related Molecular Pathways 11
- Co-authors
- Jianfeng Zhou (68 shared papers)Qinglei Gao (53 shared papers)Zheng Hu (10 shared papers)Shixuan Wang (37 shared papers)Gang Xu (28 shared papers)Gang Chen (29 shared papers)Shujie Liao (13 shared papers)Wei Wang (20 shared papers)
- Journals
- Cancer Letters (13 papers)Oncotarget (12 papers)PLoS ONE (11 papers)Gynecologic Oncology (8 papers)Clinical Cancer Research (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ding Ma
244 papers receiving 7.0k citations
Ding Ma's Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 1.4k
- Oncology 1.7k
- Immunology 1.0k
- Molecular Biology 3.2k
- Biochemistry 273
Countries citing papers authored by Ding Ma
This map shows the geographic impact of Ding Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Ma more than expected).
Fields of papers citing papers by Ding Ma
This network shows the impact of papers produced by Ding Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Ma. The network helps show where Ding Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 247 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human papillomavirus vaccine against cervical cancer: Opportunity and challenge Hit paper breakdown → | 2019 | 323 |
| 2 | Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response Hit paper breakdown → | 2021 | 308 |
| 3 | 2018 | 244 | |
| 4 | Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Hit paper breakdown → | 2022 | 220 |
| 5 | 2007 | 183 | |
| 6 | 2011 | 170 | |
| 7 | 2010 | 130 | |
| 8 | 2017 | 128 | |
| 9 | 2019 | 116 | |
| 10 | 2008 | 97 | |
| 11 | 2007 | 96 | |
| 12 | 2018 | 92 | |
| 13 | 2009 | 89 | |
| 14 | 2016 | 87 | |
| 15 | 2010 | 86 | |
| 16 | 2018 | 84 | |
| 17 | 2017 | 84 | |
| 18 | 2008 | 84 | |
| 19 | 2004 | 82 | |
| 20 | 2014 | 78 |
About Ding Ma
Ding Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Immunology, having authored 247 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (21 papers), Virus-based gene therapy research (21 papers), Cancer, Hypoxia, and Metabolism (13 papers), Cancer Cells and Metastasis (12 papers), Immunotherapy and Immune Responses (12 papers), MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.7k citations), Immunology (1.0k citations), Molecular Biology (3.2k citations) and Biochemistry (273 citations). Ding Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jianfeng Zhou, Qinglei Gao, Zheng Hu, Shixuan Wang, Gang Xu, Gang Chen, Shujie Liao, Wei Wang, Song‐Yang Wu and Yi‐Zhou Jiang. Their work appears in journals such as Cancer Letters, Oncotarget, PLoS ONE, Gynecologic Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.